UBS Group AG

SEC CIK: 0001610520
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

DMAAR holding history

Drugs Made In America Acquisition Corp. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DMAAR overview All 13F holders of DMAAR Full Q2 2026 holdings

Shares (Q2 2026): 108
Value: $12
% of portfolio: <0.1%
Quarters held: 2; Since Q3 2025

Holdings of DMAAR by UBS Group AG, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	108	$12	<0.1%	+108	New	Holders
Q4 2025	0	$0	0.0%	−150−100.0%	Sold out	Holders
Q3 2025	150	$33	<0.1%	+150	New	Holders